Qingdao Baheal Medical INC. (SHE:301015)

SHE:301015 Revenue

Qingdao Baheal Medical INC. had revenue of 1.78B CNY in the quarter ending June 30, 2026, a decrease of -7.05%. This brings the company's total for the last twelve months to 7.31B, down -6.87% year-over-year. In the year 2025, Qingdao Baheal Medical INC. had annual revenue of 7.51B, down -7.26%. That makes Qingdao Baheal Medical INC. the 7,201st largest company in the world by revenue and 1,032nd in China.

• Revenue (ttm): 7.31B
• Revenue Growth: -6.87%
• P/S Ratio: 1.61
• Revenue / Employee: 2.93M
• Employees: 2,493
• Market Cap: 11.17B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Brand Operation Business Segment 5.62B 74.9%
• Pharmaceutical Wholesale and Distribution Business Division 1.46B 19.4%
• Retail Business Segment 397.66M 5.3%
• Unallocated Other Operating Income 26.67M 0.4%

By Geography

Chart

• Shandong Province 2.14B 28.5%
• East China (Except Shandong Province) 1.43B 19.0%
• Southern China 758.84M 10.1%
• Northern China 745.24M 9.9%
• Hong Kong 718.05M 9.6%
• Southwest China 520.71M 6.9%
• Central China 475.64M 6.3%
• Other 725.48M 9.7%

Fiscal year ended Dec 31, 2025 See the full SHE:301015 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.51B	-587.94M	-7.26%
Dec 31, 2024	8.09B	-161.54M	-1.96%
Dec 31, 2023	8.26B	746.38M	9.94%
Dec 31, 2022	7.51B	458.05M	6.50%
Jan 1, 2022	7.05B	1.17B	19.94%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 19, 2026

Data Sources Report a data error